Back
Janux Therapeutics Quote, Financials, Valuation and Earnings
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Buy
57
JANX
Janux Therapeutics
Last Price:
54.80
Seasonality Move:
13.55%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret LoopholeJanux Therapeutics Price Quote
$54.80
-0.48 (-0.87%)
(Updated: November 6, 2024 at 5:55 PM ET)
Janux Therapeutics Key Stats
Buy
57
Janux Therapeutics (JANX)
is a Buy
Day range:
$54.01 - $56.14
52-week range:
$5.65 - $65.60
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
178.99
P/B ratio:
4.38%
Volume:
447.3K
Avg. volume:
626.8K
1-year change:
716.54%
Market cap:
$2.9B
Revenue:
$8.1M
EPS:
$-0.9
How Much Does Janux Therapeutics Make?
-
How Much Are Janux Therapeutics's Sales Annually?
JANX Revenues are $8.1M -
How Much Profit Does Janux Therapeutics's Make A Year?
JANX net income is -$58.3M
Is Janux Therapeutics Growing As A Company?
-
What Is Janux Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 7.42% -
What Is Janux Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Janux Therapeutics Stock Price Performance
-
Did Janux Therapeutics Stock Go Up Last Month?
Janux Therapeutics share price went up by 22.79% last month -
Did JANX's Share Price Rise Over The Last Year?
JANX share price rose by 716.54% over the past 1 year
What Is Janux Therapeutics 52-Week High & Low?
-
What Is Janux Therapeutics’s 52-Week High Share Price?
Janux Therapeutics has traded as high as $65.60 over the past 52 weeks -
What Is Janux Therapeutics’s 52-Week Low Share Price?
Janux Therapeutics has traded as low as $5.65 over the past 52 weeks
Janux Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Janux Therapeutics?
-
How Much Debt Does Janux Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Janux Therapeutics Have?
Cash and short term investments quarterly total is $646.3M -
What Is Janux Therapeutics’s Book Value Per Share?
Book value per share is 12.61
Is Janux Therapeutics Cash Flow Positive?
-
What Is JANX Cash Flow From Operations?
Cash flow from operations (TTM) is -$46.5M -
What Is Janux Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $382.4M -
What Is Janux Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$354.9M
Janux Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
JANX return on invested capital is -9.55% -
What Is Janux Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -8.85% -
What Is JANX Return On Equity?
ROE is a measure of profitability and is -9.55%
Janux Therapeutics Earnings Date & Stock Price
-
What Is Janux Therapeutics's Stock Price Today?
A single share of JANX can be purchased today for 55.28 -
What Is Janux Therapeutics’s Stock Symbol?
Janux Therapeutics trades on the nasdaq under the ticker symbol: JANX -
When Is Janux Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Janux Therapeutics is scheduled on November 7, 2024 -
When Is JANX's next ex-dividend date?
Janux Therapeutics's next ex-dividend date is November 6, 2024 -
How To Buy Janux Therapeutics Stock?
You can buy Janux Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Janux Therapeutics Competitors
-
Who Are Janux Therapeutics's Competitors?
Below is a list of companies who compete with Janux Therapeutics or are related in some way:
Janux Therapeutics Dividend Yield
-
What Is JANX Dividend Yield?
Janux Therapeutics’s dividend yield currently is 0% -
What Is Janux Therapeutics’s Payout Ratio?
Janux Therapeutics’s payout ratio is 0% -
When Did Janux Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 6, 2024 -
What Is Janux Therapeutics’s Dividend Per Share?
Janux Therapeutics pays a dividend of $0.00 per share
Janux Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 62.59% |
| Revenue: | 741.72% | 930.8% |
Analyst Recommendations
| Buy Recommendations: | 9 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 63.64 |
| Upside from Last Price: | 15.12% |